Skip to content
Link copied!

應用奈米醫材科技股份有限公司 2025 Sustainability Report

  • Reporting Year:2025

  • Disclosure Period:2025/01/01 ~ 2025/12/31

  • Industry:生技醫療業

  • Verification Standards:本報告書依循全球報告倡議組織(GRI),永續性報導準則2021 年版編制,並依據SASB 醫療設備與用品行業準則(HC-MS)、上櫃 公司編製與申報永續報告書作業辦法及TCFD揭露氣候相關財務揭 露建議等進行編製撰寫。

Report summary

  • This page summarizes the 2025 sustainability report and ESG report PDF source for 應用奈米醫材科技股份有限公司 (6612).
  • The reporting period is 2025/01/01 to 2025/12/31, in the 生技醫療業 industry.
  • third-party verification or assurance body information is not currently provided; this can be used to review report verification, assurance, and disclosure standards.
  • Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.

Report details

Company
應用奈米醫材科技股份有限公司(6612)
Reporting Year
2025
Disclosure Period
2025/01/01 to 2025/12/31
Industry
生技醫療業
Third-party information
third-party verification or assurance body information is not currently provided
PDF source
The original ESG report PDF can be downloaded or opened from this page

2025 ESG Metrics and Industry Comparison

Greenhouse Gas Emissions

Scope 1 Emissions (Tons CO2e)
4.3
Reporting Boundary:已完成母公司
Verification:否
Scope 2 Emissions (Tons CO2e)
505
Reporting Boundary:已完成母公司
Verification:否
Scope 3 Emissions (Tons CO2e)
Not disclosed
Reporting Boundary:Not disclosed
Verification:否

Energy Management

Renewable Energy Share
Not disclosed
Reporting Boundary:Not disclosed
Verification:Not disclosed

Water Management

Water Use (Metric Tons)
2,144
Reporting Boundary:新竹科學園區新竹縣竹北市生醫路2段12號1樓、12號4樓、16號4樓、 新竹科學園區新竹縣竹北市生醫五路66號3樓之3、3樓之5
Verification:Not disclosed

Board of Directors

Board Seats (Including Independent Directors)
7
Independent Director Seats
3
Female Director Ratio
14.3%
Ranked 58 among 96 companies in the same industry (percentile 26).
Board Meeting Attendance Rate
95%
Ranked 64 among 96 companies in the same industry (percentile 33).
Independent Director Ratio
42.9%
Ranked 40 among 96 companies in the same industry (percentile 40).

Source: Taiwan Stock Exchange / Taipei Exchange, Corporate ESG Disclosure Summary (2025), under the Open Government Data License, version 1.0. Open Government Data License, Version 1.0

How to use this report

  • Compare how 應用奈米醫材科技股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2025.
  • Confirm the reporting period, third-party verification or assurance information, and downloadable ESG report PDF source.
  • Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.

Historical Reports

Reports from the Same Industry

How can this public report be used as a reference?

Compare chapter structures, metrics, and public disclosure approaches, then check the original page for context. A peer’s disclosure is not evidence about your company; use your own data and supporting documents for actual disclosures.

Check report Build report